News
ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback